Adapting to regional trends in health economics and supporting investment
Healthcare in Asia is undergoing major transformation. Rapid economic growth and shifting epidemiological trends have led to increased expectations of both quality and affordability. Naturally, the agenda for growth and change in healthcare throughout Asia translates to an exciting but challenging business environment for the life sciences industry, especially for pharmaceutical and biotech companies looking to expand into the region.
The prospects for pharma-healthcare businesses in Asia are linked to a series of key questions: Which countries have the most industry-friendly approval processes? What are the various payment structures? What are the boundaries for relations with key opinion leaders? Where are the most attractive opportunities for investment and collaboration?
The FT Asia Pharma-Healthcare Summit takes place on 20 May 2015 in Singapore. Leading professionals and thought leaders will answer questions, propose solutions and discuss the future of the healthcare sector throughout the Asia-Pacific region.